Form 4: Rachesky Reports Lionsgate Studios Corp. Share Transactions

Mark H. Rachesky, M.D., a Director and 10% Owner of Lionsgate Studios Corp., has reported transactions involving common shares, including director fees and restricted share units.

Summary

• Mark H. Rachesky, M.D., a Director and 10% Owner of Lionsgate Studios Corp. (LION), reported several transactions on April 1, 2026.
• He acquired 7,983 common shares as director fees at a price of $9.52 per share.
• Additionally, 20,107 restricted share units were noted, which are payable in common shares upon vesting, with one annual installment scheduled for November 28, 2026.
• The filing details beneficial ownership across multiple investment vehicles, including MHR Capital Partners Master Account LP, MHR Capital Partners (100) LP, MHR Institutional Partners II LP, MHR Institutional Partners IIA LP, MHR Institutional Partners III LP, and MHR Institutional Partners IV LP.
• Dr. Rachesky, through various affiliated entities, has the power to vote or direct the vote and dispose of shares held in these accounts, though he disclaims beneficial ownership beyond his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions and compensation without indicating significant positive or negative developments for the company.

Positives

• Acquisition of 7,983 common shares through director fees indicates ongoing compensation in equity.
• The reporting person holds a significant beneficial ownership across multiple investment entities, suggesting substantial long-term investment in the company.

Negatives

• The filing does not contain explicit negative financial results or operational setbacks.
• While not a direct negative, the complex structure of beneficial ownership across multiple entities could be perceived as opaque by some investors.

Risks

• The filing mentions a Voting and Standstill Agreement, the details of which are not fully disclosed, which could impose certain restrictions or obligations.
• The disclaimer of beneficial ownership beyond pecuniary interest for a large number of shares held through various entities could be a point of scrutiny.

Future Outlook

The filing does not contain forward-looking statements or guidance. However, the vesting of restricted share units on November 28, 2026, indicates future share issuances.

Management Comments

• Dr. Rachesky, through various entities, may be deemed to beneficially own shares held for the account of several LPs, but disclaims beneficial ownership except to the extent of their pecuniary interest therein.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The nature of these transactions, particularly director fees paid in stock and the complex beneficial ownership structures, is common among significant investors and company insiders in the media and entertainment sector.

Related Party Transactions

• The filing details beneficial ownership through various MHR entities, indicating complex related-party relationships concerning investment management and general partnership structures.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director and 10% owner, and the upcoming vesting of restricted share units, could influence share supply and ownership structure.
• Management: The use of stock as director fees aligns management's interests with shareholders.

Next Steps

• Vesting of restricted share units on November 28, 2026.

Key Dates

Keywords

Form 4, SEC Filing, Lionsgate Studios Corp, LION, Mark H. Rachesky, Director, 10% Owner, Common Shares, Beneficial Ownership, Director Fees, Restricted Share Units, Equity Transaction